BME •
Healthcare •
Diagnostics & Research •
Quote as of 07/21/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeBME
Market Capitalization53.87 mln
Float10.87 mln
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-2.55
Likely reliable
Relative Strength
23
/ 100
Significantly lagging
Debt / Equity
0.27
Very low leverage
ROE
-16.93
Negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in Barcelona in 2006, Pangaea Oncology S.A. helps cancer patients across Spain and the wider European Union by offering a broad set of specialized medical services. The company runs advanced laboratory tests to study tumors at a genetic level, supports clinical trials, and develops tools to help doctors choose the most effective treatments for individual patients. It also works to identify new biological markers that can improve how cancer is diagnosed and treated.
